Quiang et al. demonstrated that high MAFB protein expression is associated with resistance to proteasome inhibitors, bortezomib and carfilzomib in MM cell lines, and that MAFB mediated proteasome inhibitor resistance [30]. Here, MAFB is linked to Miyoshi myopathy.